Biovest International Inc.
Biovest International, Inc. has announced that it conducted a formal clinical guidance meeting with the U.S. Food and Drug Administration (FDA) to determine the most expeditious U.S. registration pathway for BiovaxID™, its personalized cancer vaccine for the consolidation treatment of follicular n...Read More
facebook icon
twitter icon
comments icon
up arrow
up arrow
Don't Miss A Thing!

Our news stories are now available through email. Simply enter your email address below and click “Subscribe” to see the new stories every day.

×